← Leaderboards
Markus Anton Wimmer
Rush University Medical Center
$2,962,737
Attributed
$4,356,299
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $812.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,356,299 · 5
By mechanism
R01$3,332,175 · 2
R21$807,853 · 2
R03$216,271 · 1
Top collaborators
- Joseph J Crisco3 shared
- Nadim James Hallab2 shared
- John L Hamilton2 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Warren Knudson$3,452,272
- Nadim James Hallab$2,091,646
- John L Hamilton$272,352
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoFutureMotionSuccessDesignTissuesSurfaceInvestigationPre-ClinicalImplantReportingGaitPreclinical TestingProgramsMechanicsProsthesisKneeCellsIn Vitro TestingOperative Surgical ProceduresJointsBaseTitaniumPerformance
Grant awards (14)
Advancing Hemiarthroplasty: Predicting in vivo performance of cartilage bearing systems through benchtop and ex vivo testing.$610,578
R01 · FY2025 · AR
Use of Bacterial Biofilm Disrupting Antibodies to Prevent and Treat Periprosthetic Joint Infection$202,303
R21 · FY2025 · AR
Advancing Hemiarthroplasty: Predicting in vivo performance of cartilage bearing systems through benchtop and ex vivo testing.$638,180
R01 · FY2024 · AR
Use of Bacterial Biofilm Disrupting Antibodies to Prevent and Treat Periprosthetic Joint Infection$173,800
R21 · FY2024 · AR
Advancing Hemiarthroplasty: Predicting in vivo performance of cartilage bearing systems through benchtop and ex vivo testing.$730,514
R01 · FY2023 · AR
Determination of excessive immune reactivity to real time implant debris generate$196,250
R21 · FY2018 · EB · contact PI
Determination of excessive immune reactivity to real time implant debris generate$235,500
R21 · FY2017 · EB · contact PI
Wear Testing for Enhanced Prediction of TKR Clinical Performance$337,365
R01 · FY2014 · AR · contact PI
Wear Testing for Enhanced Prediction of TKR Clinical Performance$327,038
R01 · FY2013 · AR · contact PI
Wear Testing for Enhanced Prediction of TKR Clinical Performance$344,250
R01 · FY2012 · AR · contact PI
Wear Testing for Enhanced Prediction of TKR Clinical Performance$344,250
R01 · FY2011 · AR · contact PI
Daily Activity of TKR Patients as Input for Wear Testing$70,417
R03 · FY2008 · AR · contact PI
Daily Activity of TKR Patients as Input for Wear Testing$71,854
R03 · FY2007 · AR · contact PI
Daily Activity of TKR Patients as Input for Wear Testing$74,000
R03 · FY2006 · AR · contact PI